Combination Therapy of the Active KRAS-Targeting Antibody inRas37 and a PI3K Inhibitor in Pancreatic Cancer.

Lee, Ji Eun; Woo, Min Gyu; Jung, Kyung Hee; Kang, Yeo Wool; Shin, Seung-Min; Son, Mi Kwon; Fang, Zhenghuan; Yan, Hong Hua; Park, Jung Hee; Yoon, Young-Chan; Kim, Yong-Sung; Hong, Soon-Sun

Lee, Ji Eun; Woo, Min Gyu; Jung, Kyung Hee; Kang, Yeo Wool; Shin, Seung-Min; Son, Mi Kwon; Fang, Zhenghuan; Yan, Hong Hua; Park, Jung Hee; Yoon, Young-Chan; Kim, Yong-Sung; Hong, Soon-Sun.

Afiliación

Lee JE; Department of Biomedical Sciences, College of Medicine, and Program in Biomedical Science & Engineering, Inha University, Incheon 22332, Republic of Korea.
Woo MG; Department of Biomedical Sciences, College of Medicine, and Program in Biomedical Science & Engineering, Inha University, Incheon 22332, Republic of Korea.
Jung KH; Department of Biomedical Sciences, College of Medicine, and Program in Biomedical Science & Engineering, Inha University, Incheon 22332, Republic of Korea.
Kang YW; Department of Biomedical Sciences, College of Medicine, and Program in Biomedical Science & Engineering, Inha University, Incheon 22332, Republic of Korea.
Shin SM; Department of Molecular Science and Technology, Ajou University, Suwon 16499, Republic of Korea.
Son MK; Department of Biomedical Sciences, College of Medicine, and Program in Biomedical Science & Engineering, Inha University, Incheon 22332, Republic of Korea.
Fang Z; Department of Biomedical Sciences, College of Medicine, and Program in Biomedical Science & Engineering, Inha University, Incheon 22332, Republic of Korea.
Yan HH; Department of Biomedical Sciences, College of Medicine, and Program in Biomedical Science & Engineering, Inha University, Incheon 22332, Republic of Korea.
Park JH; Department of Biomedical Sciences, College of Medicine, and Program in Biomedical Science & Engineering, Inha University, Incheon 22332, Republic of Korea.
Yoon YC; Department of Biomedical Sciences, College of Medicine, and Program in Biomedical Science & Engineering, Inha University, Incheon 22332, Republic of Korea.
Kim YS; Department of Molecular Science and Technology, Ajou University, Suwon 16499, Republic of Korea.
Hong SS; Department of Biomedical Sciences, College of Medicine, and Program in Biomedical Science & Engineering, Inha University, Incheon 22332, Republic of Korea.

Biomol Ther (Seoul) ; 30(3): 274-283, 2022 May 01.

Article en En | MEDLINE | ID: mdl-34663758

Palabras clave

BEZ-235; KRAS; PI3K; Pancreatic cancer; Targeting antibody

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Biomol Ther (Seoul) Año: 2022 Tipo del documento: Article